Dianxiong Zou, PhD

I received my PhD in Biological Sciences from the University at Buffalo (New York). My doctoral research consisted of understanding the functions and signaling mechanisms of G-protein coupled receptors in the protozoan Tetrahymena thermophila. This research led me to uncover a novel, nociceptive oxidant receptor and its endogenous, iron-containing ligand. My interest in a multi-disciplinary approach to biology has drawn me to the Majeti lab, which I joined in November 2018. I am currently involved in in vitro and in vivo testing of pharmacological compounds and their nanoparticle delivery systems.


Email: dzou@tamu.edu
Phone: +1-979-436-9035
Mobile: +1-716-909-3362

Peer-reviewed publications

  1. A highly potent lymphatic system–targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus. Ganugula R, Arora M, Zou D, Agarwal SK, Mohan C, Kumar MNVR. Sci. Adv. 6: eabb3900, 2020. This article is highlighted in Nature Reviews Rheumatology
  2. D. Zou#, R. Ganugula#, M. Arora#, M. B. Nabity, D. Sheikh-Hamad and M. N. V. Ravi Kumar. Oral delivery of nanoparticle urolithin A normalizes cellular stress and improves survival in mouse model of cisplatin-induced AKI. Am J Physiol Renal Physiol, 317, F1255-F1264, 2019  [#equal contributing authors] (Selected for APS Select award)